Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma
Abstract Dysregulated cholesterol metabolism is a hallmark of many cancers, including glioblastoma (GBM), but its role in disease progression is not well understood. Here, we identified cholesterol 24‐hydroxylase (CYP46A1), a brain‐specific enzyme responsible for the elimination of cholesterol throu...
| Príomhchruthaitheoirí: | , , , , , , , , , , , , , , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
Springer Nature
2019-11-01
|
| Sraith: | EMBO Molecular Medicine |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.15252/emmm.201910924 |